Menu Search
Equities

Daiichi Sankyo Co Ltd

4568:TYO

Daiichi Sankyo Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)4,435.00
  • Today's Change-48.00 / -1.07%
  • Shares traded4.38m
  • 1 Year change+9.34%
  • Beta1.2579
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Daiichi Sankyo Co Ltd grew revenues 25.28% from 1.28tn to 1.60tn while net income improved 83.84% from 109.19bn to 200.73bn.
Gross margin76.11%
Net profit margin14.26%
Operating margin17.26%
Return on assets8.43%
Return on equity15.57%
Return on investment10.51%
More ▼

Cash flow in JPYView more

In 2024, Daiichi Sankyo Co Ltd increased its cash reserves by 46.45%, or 205.26bn. The company earned 590.04bn from its operations for a Cash Flow Margin of 36.84%. In addition the company used 282.64bn on investing activities and also paid 123.56bn in financing cash flows.
Cash flow per share164.63
Price/Cash flow per share27.41
Book value per share855.86
Tangible book value per share691.61
More ▼

Balance sheet in JPYView more

Daiichi Sankyo Co Ltd has a Debt to Total Capital ratio of 5.89%, a lower figure than the previous year's 6.37%.
Current ratio2.94
Quick ratio2.24
Total debt/total equity0.0626
Total debt/total capital0.0589
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 66.67% and 85.90%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.87%
Div growth rate (5 year)16.47%
Payout ratio (TTM)45.69%
EPS growth(5 years)17.03
EPS (TTM) vs
TTM 1 year ago		69.77
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.